Results 201 to 210 of about 842,971 (238)
Some of the next articles are maybe not open access.
Current Medicinal Chemistry, 2019
BACKGROUND Despite the recent advances in the treatment of acute coronary syndromes (ACS), patients with ACS are still exposed to an increased risk for adverse cardiovascular events, while their prognosis is difficult to determine.
E. Zacharia +7 more
semanticscholar +3 more sources
BACKGROUND Despite the recent advances in the treatment of acute coronary syndromes (ACS), patients with ACS are still exposed to an increased risk for adverse cardiovascular events, while their prognosis is difficult to determine.
E. Zacharia +7 more
semanticscholar +3 more sources
Circulating cell-derived microparticles as biomarkers in cardiovascular disease.
Biomarkers in Medicine, 2016Cardiovascular diseases (CVDs) are a common cause of death, and a search for biomarkers for risk stratification is warranted. Elevated levels of cell-derived microparticles (MPs) are found in patients with CVD and in groups with risk factors for CVD ...
Å. Thulin +3 more
semanticscholar +3 more sources
Cell-derived microparticles in haemostasis and vascular medicine
Thrombosis and Haemostasis, 2009 SummaryConsiderable interest for cell-derived microparticles has emerged, pointing out their essential role in haemostatic response and their potential as disease markers, but also their implication in a wide range of physiological and pathological processes. They derive from different cell types including platelets – the main source of microparticles –
L. Burnier +3 more
semanticscholar +5 more sources
Red blood cell-derived microparticles: An overview.
Blood Cells, Molecules, and Diseases, 2016The red blood cell (RBC) is historically the original parent cell of microparticles (MPs). In this overview, we describe the discovery and the early history of red cell-derived microparticles (RMPs) and present an overview of the evolution of RMP. We report the formation, characteristics, effects of RMP and factors which may affect RMP evaluation.
M. Westerman, J. Porter
semanticscholar +4 more sources
Advances in Materials, 2023
Tumor‐cell‐derived microparticles (MPs) can function as anticancer drug‐delivery carriers. However, short blood circulation time, large‐size‐induced insufficient tumor accumulation and penetration into tumor parenchyma, as well as limited cellular ...
Haojie Liu +12 more
semanticscholar +1 more source
Tumor‐cell‐derived microparticles (MPs) can function as anticancer drug‐delivery carriers. However, short blood circulation time, large‐size‐induced insufficient tumor accumulation and penetration into tumor parenchyma, as well as limited cellular ...
Haojie Liu +12 more
semanticscholar +1 more source
Angewandte Chemie, 2021
Positioning essential elements of photodynamic therapy (PDT) to mitochondria can conquer the rigorously spatiotemporal limitation of reactive oxygen species (ROS) transfer and make considerable differences in PDT.
Liping Zuo +10 more
semanticscholar +1 more source
Positioning essential elements of photodynamic therapy (PDT) to mitochondria can conquer the rigorously spatiotemporal limitation of reactive oxygen species (ROS) transfer and make considerable differences in PDT.
Liping Zuo +10 more
semanticscholar +1 more source
"Kill" the messenger: Targeting of cell-derived microparticles in lupus nephritis.
Autoimmunity Reviews, 2016Immune complex (IC) deposition in the glomerular basement membrane (GBM) is a key early pathogenic event in lupus nephritis (LN). The clarification of the mechanisms behind IC deposition will enable targeted therapy in the future. Circulating cell-derived microparticles (MPs) have been proposed as major sources of extracellular autoantigens and ICs and
C. Nielsen +3 more
semanticscholar +6 more sources
Circulating Cell-Derived Microparticles in Crohn?s Disease [PDF]
Digestive Diseases and Sciences, 2005 Procoagulant membrane microparticles can be released from activated or apoptotic cells in response to various environmental stimuli. The aim of this study was to investigate the presence of microparticles in Crohn's disease and to assess their variations after infliximab therapy.
P. Chamouard +8 more
openaire +2 more sources
Red cell-derived microparticles (RMP) as haemostatic agent
Thrombosis and Haemostasis, 2013SummaryAmong circulating cell-derived microparticles, those derived from red cells (RMP) have been least well investigated. To exploit potential haemostatic benefit of RMP, we developed a method of producing them in quantity, and here report on their haemostatic properties. High-pressure extrusion of washed RBC was employed to generate RMP.
W. Jy +4 more
semanticscholar +4 more sources